Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Marina Scolnik
Combination Therapy Versus Celecoxib, a Single Selective COX-2 Agent, to Reduce Gastrointestinal Toxicity in Arthritic Patients: Patient and Cost-Effectiveness Considerations
Open Access Rheumatology: Research and Reviews
Rheumatology
Related publications
Gastrointestinal Tolerability of the Selective Cyclooxygenase-2 (COX-2) Inhibitor Rofecoxib Compared With Nonselective COX-1 and COX-2 Inhibitors in Osteoarthritis
Archives of Internal Medicine
Cost-Effectiveness of First-Line Versus Delayed Use of Combination Dapagliflozin and Metformin in Patients With Type 2 Diabetes
Scientific Reports
Multidisciplinary
Cost-Effectiveness Analysis of Continuous Versus Intermittent Celecoxib Use for HIP and Knee Osteoarthritis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of Salmeterol/Fluticasone Combination Therapy vs. Fluticasone Propionate in Japanese Asthmatic Patients
Yakugaku Zasshi
Pharmacology
Pharmaceutical Science
The Cost-Effectiveness of Alogliptin Versus Sulfonylurea as Add-On Therapy to Metformin in Patients With Uncontrolled Type 2 Diabetes Mellitus
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Risk of Gastrointestinal Effects With COX-2 Inhibitors and NSAIDs: Study Conclusions Do Not Reflect Findings for Celecoxib
BMJ
5-Fu Therapeutic Drug Monitoring as a Valuable Option to Reduce Toxicity in Patients With Gastrointestinal Cancer
Oncotarget
Oncology
Overexpression of COX-2 in Celecoxib-Resistant Breast Cancer Cell Lines
Journal of Surgical Research
Surgery
Risk of Gastrointestinal Effects With COX-2 Inhibitors and NSAIDs: What Does Evidence From Randomised Trials Show About Celecoxib?
BMJ
